pEGFR promotes the neural function recovery after decompression of compressed spinal cord injury

Abstract Purpose Investigating the roles of phosphorylated epidermal growth factor receptor (pEGFR) in the recovery of neural function after decompression of CSCI, therefore provide experimental basis for the development of therapeutic strategies and medicines for treating CSCI. Methods A CSCI model was established with a customized device, and was then subjected to spinal decompression. The motor functions were monitored by the Basso, Beattie & Bresnahan（BBB） locomotor rating scale; the number of axonal myelinated fibers was estimated by staining with luxol fast blue (LFB); pEGFR and phosphorylated Akt1 (pAkt1) were detected by Western blot; pEGFR+-NG2+(NG2+ cells are precursor to oligodendrocytes and pAkt1+-NG2+ cells were detected by double-labeling immunefluorescence assay. Results After decompression of CSCI, the BBB scores and the number of myelinated nerve fibers gradually increased with time. Meanwhile, the expression of pEGFR and pAkt1 were up-regulated and the number of pEGFR+-NG2+ and pAkt1+-NG2+ cells increased consistent with the changes of motor functions and the number of myelinated nerve fibers. Whereas, significant decreases in BBB scores, expression level of pAkt1, as well as numbers of myelinated nerve fibers, and pAkt1+-NG2+ cells were observed after inhibition of expression. Conclusions Up-regulated expression of pEGFR can promote recovery of neurological functions in rats with CSCI. This effect is achieved by activation of pAkt1（a downstream signal molecule of pEGFR）, which subsequently promotes the proliferation of oligodendrocyte precursor cells (OPCs).